Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

A new approach for inflammatory bowel disease therapy.

Blander JM.

Nat Med. 2019 Apr;25(4):545-546. doi: 10.1038/s41591-019-0416-4. No abstract available.

PMID:
30936545
2.

A key ingredient for priming killer T cells.

Barbet G, Blander JM.

Science. 2018 Nov 9;362(6415):641-642. doi: 10.1126/science.aav3683. No abstract available.

PMID:
30409872
3.

On cell death in the intestinal epithelium and its impact on gut homeostasis.

Blander JM.

Curr Opin Gastroenterol. 2018 Nov;34(6):413-419. doi: 10.1097/MOG.0000000000000481. Review.

PMID:
30169459
4.

Exploiting vita-PAMPs in vaccines.

Blander JM, Barbet G.

Curr Opin Pharmacol. 2018 Aug;41:128-136. doi: 10.1016/j.coph.2018.05.012. Epub 2018 Jun 8. Review.

5.

Detection of a vita-PAMP STINGs cells into reticulophagy.

Moretti J, Blander JM.

Autophagy. 2018;14(6):1102-1104. doi: 10.1080/15548627.2018.1441471. Epub 2018 May 21.

6.

Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses.

Barbet G, Sander LE, Geswell M, Leonardi I, Cerutti A, Iliev I, Blander JM.

Immunity. 2018 Mar 20;48(3):584-598.e5. doi: 10.1016/j.immuni.2018.02.015. Epub 2018 Mar 13.

7.

Regulation of the Cell Biology of Antigen Cross-Presentation.

Blander JM.

Annu Rev Immunol. 2018 Apr 26;36:717-753. doi: 10.1146/annurev-immunol-041015-055523. Epub 2018 Feb 28. Review.

8.

Measuring Innate Immune Responses to Bacterial Viability.

Moretti J, Vabret N, Blander JM.

Methods Mol Biol. 2018;1714:167-190. doi: 10.1007/978-1-4939-7519-8_11.

PMID:
29177862
9.

STING Senses Microbial Viability to Orchestrate Stress-Mediated Autophagy of the Endoplasmic Reticulum.

Moretti J, Roy S, Bozec D, Martinez J, Chapman JR, Ueberheide B, Lamming DW, Chen ZJ, Horng T, Yeretssian G, Green DR, Blander JM.

Cell. 2017 Nov 2;171(4):809-823.e13. doi: 10.1016/j.cell.2017.09.034. Epub 2017 Oct 19.

10.

Regulation of inflammation by microbiota interactions with the host.

Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D.

Nat Immunol. 2017 Jul 19;18(8):851-860. doi: 10.1038/ni.3780. Review.

11.

The many ways tissue phagocytes respond to dying cells.

Blander JM.

Immunol Rev. 2017 May;277(1):158-173. doi: 10.1111/imr.12537. Review.

12.

Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.

Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A.

J Exp Med. 2017 May 1;214(5):1559. doi: 10.1084/jem.2015028204172017c. Epub 2017 Apr 18. No abstract available.

13.

Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs.

Cummings RJ, Barbet G, Bongers G, Hartmann BM, Gettler K, Muniz L, Furtado GC, Cho J, Lira SA, Blander JM.

Nature. 2016 Nov 24;539(7630):565-569. doi: 10.1038/nature20138. Epub 2016 Nov 9.

14.

Cell-autonomous stress responses in innate immunity.

Moretti J, Blander JM.

J Leukoc Biol. 2017 Jan;101(1):77-86. doi: 10.1189/jlb.2MR0416-201R. Epub 2016 Oct 12. Review.

15.

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.

Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A.

J Exp Med. 2016 Sep 19;213(10):2167-85. doi: 10.1084/jem.20150282. Epub 2016 Sep 12. Erratum in: J Exp Med. 2017 May 1;214(5):1559.

16.

Apoptosis in response to microbial infection induces autoreactive TH17 cells.

Campisi L, Barbet G, Ding Y, Esplugues E, Flavell RA, Blander JM.

Nat Immunol. 2016 Sep;17(9):1084-92. doi: 10.1038/ni.3512. Epub 2016 Jul 25.

17.

The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.

Blander JM.

Immunol Rev. 2016 Jul;272(1):65-79. doi: 10.1111/imr.12428. Review.

18.

CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.

Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, Zhang J, Mizoguchi E, Zelic M, Kelliher MA, Blander JM, Ting AT.

Cell Rep. 2016 Jun 14;15(11):2449-61. doi: 10.1016/j.celrep.2016.05.032. Epub 2016 Jun 2.

19.

Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease.

Blander JM.

FEBS J. 2016 Jul;283(14):2720-30. doi: 10.1111/febs.13771. Epub 2016 Jun 22. Review.

20.

A central role for Notch in effector CD8(+) T cell differentiation.

Backer RA, Helbig C, Gentek R, Kent A, Laidlaw BJ, Dominguez CX, de Souza YS, van Trierum SE, van Beek R, Rimmelzwaan GF, ten Brinke A, Willemsen AM, van Kampen AH, Kaech SM, Blander JM, van Gisbergen K, Amsen D.

Nat Immunol. 2014 Dec;15(12):1143-51. doi: 10.1038/ni.3027. Epub 2014 Oct 26.

21.

IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.

Chen L, He Z, Slinger E, Bongers G, Lapenda TLS, Pacer ME, Jiao J, Beltrao MF, Soto AJ, Harpaz N, Gordon RE, Ochando JC, Oukka M, Iuga AC, Chensue SW, Blander JM, Furtado GC, Lira SA.

Mucosal Immunol. 2015 Mar;8(2):390-402. doi: 10.1038/mi.2014.77. Epub 2014 Aug 27.

22.

A long-awaited merger of the pathways mediating host defence and programmed cell death.

Blander JM.

Nat Rev Immunol. 2014 Sep;14(9):601-18. doi: 10.1038/nri3720. Review.

PMID:
25145756
23.

TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation.

Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, Huang Y, Banerjee M, Overholtzer M, Roche PA, Tampé R, Brown BD, Amsen D, Whiteheart SW, Blander JM.

Cell. 2014 Jul 31;158(3):506-21. doi: 10.1016/j.cell.2014.04.054.

24.

Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells.

Rimmelé P, Bigarella CL, Liang R, Izac B, Dieguez-Gonzalez R, Barbet G, Donovan M, Brugnara C, Blander JM, Sinclair DA, Ghaffari S.

Stem Cell Reports. 2014 Jun 6;3(1):44-59. doi: 10.1016/j.stemcr.2014.04.015. eCollection 2014 Jul 8.

25.

Death-defining immune responses after apoptosis.

Campisi L, Cummings RJ, Blander JM.

Am J Transplant. 2014 Jul;14(7):1488-98. doi: 10.1111/ajt.12736. Epub 2014 Jun 5. Review.

26.

Nod-like receptors: key molecular switches in the conundrum of cancer.

Kent A, Blander JM.

Front Immunol. 2014 Apr 23;5:185. doi: 10.3389/fimmu.2014.00185. eCollection 2014. Review.

27.

Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes.

Moretti J, Blander JM.

Curr Opin Immunol. 2014 Feb;26:100-10. doi: 10.1016/j.coi.2013.11.003. Epub 2013 Dec 5. Review.

28.

Sensing microbial RNA in the cytosol.

Vabret N, Blander JM.

Front Immunol. 2013 Dec 25;4:468. doi: 10.3389/fimmu.2013.00468. Review.

29.

An updated view of the intracellular mechanisms regulating cross-presentation.

Nair-Gupta P, Blander JM.

Front Immunol. 2013 Nov 22;4:401. doi: 10.3389/fimmu.2013.00401. Review.

30.

Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals.

Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, Comerma L, Huang B, Blander JM, Xiong H, Mayer L, Berin C, Augenlicht LH, Velcich A, Cerutti A.

Science. 2013 Oct 25;342(6157):447-53. doi: 10.1126/science.1237910. Epub 2013 Sep 26.

31.

Vita-PAMPs: signatures of microbial viability.

Mourao-Sa D, Roy S, Blander JM.

Adv Exp Med Biol. 2013;785:1-8. doi: 10.1007/978-1-4614-6217-0_1. Review.

PMID:
23456832
32.

Designing a type I interferon signaling phagosome.

Blander JM.

Immunity. 2012 Dec 14;37(6):947-9. doi: 10.1016/j.immuni.2012.11.009.

33.

"Flagellated" cancer cells propel anti-tumor immunity.

Garaude J, Blander JM.

Oncoimmunology. 2012 Sep 1;1(6):940-942.

34.

A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade.

Agudo J, Ruzo A, Kitur K, Sachidanandam R, Blander JM, Brown BD.

Mol Ther. 2012 Dec;20(12):2257-67. doi: 10.1038/mt.2012.150. Epub 2012 Aug 7.

35.

Attacking tumor cells with a dual ligand for innate immune receptors.

Garaude J, Blander JM.

Oncotarget. 2012 Apr;3(4):361-2. No abstract available.

36.

Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells.

Blander JM, Torchinsky MB, Campisi L.

Immunol Res. 2012 Dec;54(1-3):50-68. doi: 10.1007/s12026-012-8311-9. Review.

37.

Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Blander JM, Sander LE.

Nat Rev Immunol. 2012 Feb 24;12(3):215-25. doi: 10.1038/nri3167. Review.

PMID:
22362354
38.

Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.

Garaude J, Kent A, van Rooijen N, Blander JM.

Sci Transl Med. 2012 Feb 8;4(120):120ra16. doi: 10.1126/scitranslmed.3002868.

39.

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.

Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baró T, de Heredia CD, Torán N, Català A, Torrebadell M, Fortuny C, Cusí V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Aróstegui JI, Juan M, Yagüe J, Mahlaoui N, Donadieu J, Chen K, Cerutti A.

Nat Immunol. 2011 Dec 25;13(2):170-80. doi: 10.1038/ni.2194. Erratum in: Nat Immunol. 2014 Feb;15(2):205.

40.

Co-ordination of incoming and outgoing traffic in antigen-presenting cells by pattern recognition receptors and T cells.

Nair P, Amsen D, Blander JM.

Traffic. 2011 Dec;12(12):1669-76. doi: 10.1111/j.1600-0854.2011.01251.x. Epub 2011 Aug 15. Review.

41.

Detection of prokaryotic mRNA signifies microbial viability and promotes immunity.

Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, Swanson JA, Müller M, Blander JM.

Nature. 2011 May 22;474(7351):385-9. doi: 10.1038/nature10072. Erratum in: Nature. 2011 Oct 6;478(7367):136.

42.

The unexpected link between infection-induced apoptosis and a TH17 immune response.

Brereton CF, Blander JM.

J Leukoc Biol. 2011 Apr;89(4):565-76. doi: 10.1189/jlb.0710421. Epub 2011 Jan 19. Review.

43.

ICOStomizing immunotherapies with T(H)17.

Garaude J, Blander JM.

Sci Transl Med. 2010 Oct 27;2(55):55ps52. doi: 10.1126/scitranslmed.3001722.

PMID:
20980694
44.

Responding to infection and apoptosis--a task for TH17 cells.

Brereton CF, Blander JM.

Ann N Y Acad Sci. 2010 Oct;1209:56-67. doi: 10.1111/j.1749-6632.2010.05747.x.

PMID:
20958317
45.

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Müller M, Blander JM, Tacke F, Trautwein C.

J Exp Med. 2010 Jul 5;207(7):1453-64. doi: 10.1084/jem.20091474. Epub 2010 Jun 7.

46.

Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction.

Mosoian A, Teixeira A, Burns CS, Sander LE, Gusella GL, He C, Blander JM, Klotman P, Klotman ME.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10178-83. doi: 10.1073/pnas.0914870107. Epub 2010 May 17.

47.

Infection and apoptosis as a combined inflammatory trigger.

Torchinsky MB, Garaude J, Blander JM.

Curr Opin Immunol. 2010 Feb;22(1):55-62. doi: 10.1016/j.coi.2010.01.003. Review.

48.

T helper 17 cells: discovery, function, and physiological trigger.

Torchinsky MB, Blander JM.

Cell Mol Life Sci. 2010 May;67(9):1407-21. doi: 10.1007/s00018-009-0248-3. Epub 2010 Jan 7. Review.

PMID:
20054607
49.

Innate immune cells cast an eye on DNA.

Sander LE, Blander JM.

J Mol Cell Biol. 2009 Dec;1(2):77-9. doi: 10.1093/jmcb/mjp023. Epub 2009 Sep 29.

50.

Immunology. Amino acid addiction.

Blander JM, Amsen D.

Science. 2009 Jun 5;324(5932):1282-3. doi: 10.1126/science.1175678. No abstract available.

PMID:
19498159

Supplemental Content

Loading ...
Support Center